Fiduciary Group LLC Grows Stock Holdings in The Clorox Company (NYSE:CLX)

Fiduciary Group LLC grew its position in The Clorox Company (NYSE:CLX) by 36.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,967 shares of the company’s stock after buying an additional 5,115 shares during the quarter. Fiduciary Group LLC’s holdings in Clorox were worth $2,705,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. abrdn plc grew its position in Clorox by 20.1% in the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock valued at $28,268,000 after acquiring an additional 33,135 shares in the last quarter. International Assets Investment Management LLC increased its stake in Clorox by 17,658.5% during the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after buying an additional 481,725 shares during the period. Adage Capital Partners GP L.L.C. acquired a new stake in Clorox during the 3rd quarter worth approximately $6,605,000. Eagle Rock Investment Company LLC purchased a new position in Clorox in the 4th quarter valued at approximately $2,940,000. Finally, Nordea Investment Management AB grew its stake in shares of Clorox by 4.0% in the fourth quarter. Nordea Investment Management AB now owns 9,551 shares of the company’s stock worth $1,362,000 after acquiring an additional 364 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Clorox stock traded down $1.02 during mid-day trading on Friday, reaching $146.48. The company had a trading volume of 1,191,766 shares, compared to its average volume of 1,000,632. The stock’s 50-day simple moving average is $149.39 and its 200-day simple moving average is $142.60. The company has a market capitalization of $18.18 billion, a P/E ratio of 232.51, a P/E/G ratio of 2.32 and a beta of 0.43. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $178.21.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $1.08. The firm had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. Clorox’s revenue was up 16.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.98 earnings per share. On average, equities analysts predict that The Clorox Company will post 5.52 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be paid a $1.20 dividend. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.28%. Clorox’s payout ratio is 761.92%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on CLX shares. Citigroup reduced their price objective on Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 16th. UBS Group lifted their price objective on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a research note on Friday, February 2nd. Jefferies Financial Group upgraded shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price on the stock in a research note on Tuesday, March 26th. DA Davidson reiterated a “neutral” rating and issued a $162.00 price target on shares of Clorox in a research note on Wednesday, April 17th. Finally, The Goldman Sachs Group assumed coverage on shares of Clorox in a report on Friday, March 1st. They set a “sell” rating and a $140.00 price target for the company. Four investment analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $148.63.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.